G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

Clinical trial NCT02744742 · COMPLETED

Trial details

NCT number: NCT02744742
Sponsor: Nanfang Hospital, Southern Medical University
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Myelodysplastic Syndrome Allogeneic Hematopoietic Stem Cell Transplantation Conditioning

Start date: 2016-04-18
Primary completion: 2019-09-30
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.